ATE324114T1 - Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen - Google Patents

Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen

Info

Publication number
ATE324114T1
ATE324114T1 AT96931461T AT96931461T ATE324114T1 AT E324114 T1 ATE324114 T1 AT E324114T1 AT 96931461 T AT96931461 T AT 96931461T AT 96931461 T AT96931461 T AT 96931461T AT E324114 T1 ATE324114 T1 AT E324114T1
Authority
AT
Austria
Prior art keywords
gpi
anchored proteins
microdomains
caveolae
pellicle
Prior art date
Application number
AT96931461T
Other languages
English (en)
Inventor
Jan E Schnitzer
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/582,917 external-priority patent/US5776770A/en
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Application granted granted Critical
Publication of ATE324114T1 publication Critical patent/ATE324114T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Laminated Bodies (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparing Plates And Mask In Photomechanical Process (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
AT96931461T 1995-09-08 1996-09-05 Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen ATE324114T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US345395P 1995-09-08 1995-09-08
US08/582,917 US5776770A (en) 1995-09-08 1996-01-04 Isolation and uses of caveolae
US1830196P 1996-05-24 1996-05-24
US1879196P 1996-05-31 1996-05-31

Publications (1)

Publication Number Publication Date
ATE324114T1 true ATE324114T1 (de) 2006-05-15

Family

ID=27485284

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931461T ATE324114T1 (de) 1995-09-08 1996-09-05 Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen

Country Status (8)

Country Link
US (1) US6255457B1 (de)
EP (1) EP0848614B1 (de)
JP (2) JPH11514348A (de)
AT (1) ATE324114T1 (de)
AU (1) AU705945B2 (de)
CA (1) CA2228604A1 (de)
DE (1) DE69636074T2 (de)
WO (1) WO1997009055A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040115128A1 (en) * 1995-09-08 2004-06-17 Schnitzer Jan E. Targeting endothelium for tissue-specific delivery of agents
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
CA2308565A1 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
US6545139B1 (en) 1998-03-13 2003-04-08 Baylor College Of Medicine DNA sequence encoding the p99 gene and kits for the detection of neoplasia
US6737516B1 (en) * 1998-12-09 2004-05-18 Jan E. Schnitzer Immunoisolation of caveolae
JP4751556B2 (ja) * 2000-02-28 2011-08-17 ジーンシーグス, インコーポレイテッド ナノカプセルカプセル化システムおよび方法
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
US20050054088A1 (en) * 2002-11-05 2005-03-10 Rahbar Amir Mikel Method of separating plasma membrane proteins
JP2008501633A (ja) * 2004-02-11 2008-01-24 ユニバーシティ オブ ヴァージニア パテント ファウンデーション 癌の診断及び治療のためのCav3アイソフォーム及びそのδ25スプライスバリアントの阻害
EP1755686A2 (de) * 2004-06-02 2007-02-28 Sidney Kimmel Cancer Center Bildgebende und therapeutische mittel gezielt auf proteine der endothelialzelloberfläche
JP5139058B2 (ja) 2004-06-02 2013-02-06 シドニー キンメル キャンサー センター 新形成または新生脈管構造の検出、画像化および処置のための血管標的
JP2009531438A (ja) * 2006-03-24 2009-09-03 ジェンシア コーポレイション 合成脂質ラフトおよび使用方法
JP2010540466A (ja) 2007-09-24 2010-12-24 ザ ユニバーシティ オブ クイーンズランド 分子送達ベシクル
EP2542155B1 (de) 2010-03-01 2015-11-04 TAU Therapeutics LLC Bildgebungsverfahren einer krankheit
CN111700877A (zh) 2014-09-03 2020-09-25 吉倪塞思公司 治疗性纳米粒子和相关的组合物、方法和系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602005A (en) * 1989-03-03 1997-02-11 The University Of Virginia Alumni Patents Foundation Primate intra-acrosomal sperm antigen for use in a contraceptive vaccine
US5281700A (en) 1992-08-11 1994-01-25 The Regents Of The University Of California Method of recovering endothelial membrane from tissue and applications thereof

Also Published As

Publication number Publication date
DE69636074T2 (de) 2007-05-03
CA2228604A1 (en) 1997-03-13
JP2008189674A (ja) 2008-08-21
EP0848614B1 (de) 2006-04-26
WO1997009055A1 (en) 1997-03-13
AU705945B2 (en) 1999-06-03
JPH11514348A (ja) 1999-12-07
AU7013796A (en) 1997-03-27
US6255457B1 (en) 2001-07-03
DE69636074D1 (de) 2006-06-01
EP0848614A1 (de) 1998-06-24

Similar Documents

Publication Publication Date Title
ATE324114T1 (de) Isolierung der mikrodomänen von kaveolae und gpi verankerten proteinen
DE69637867D1 (de) Verfahren zur Kontrollierung der Sialylierung von durch Säugetierzellkultur hergestellten Proteinen
DE69632266T2 (de) Polymermaterial für elektrolytische membranen von brennstoffzellen
DK1264877T3 (da) Celledyrkningsbæremateriale, fremgangsmåde til samdyrkning af celler og samdyrket cellelag opnået derved
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
DE69630570D1 (de) Verfahren zur Herstellung von gestützten Membranen
DK0625069T3 (da) Fremgangsmåde til fremstilling af mikrokapsler
DK494688D0 (da) Fremgangsmaade til opbevaring eller dyrkning af celler og poroes, uorganisk baere-membran og apparat dertil
DK165221C (da) Belagte transplantater og fremgangsmaade til belaegning af disse
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
ATE227579T1 (de) Verfahren zur herstellung von makrophagen und ausrüstungen zur durchführung dieses verfahrens
TR199800947T2 (xx) Dinamik sistemler i�in uyarlanabilir kalman filtreleme y�ntemi.
DE69433822D1 (de) Humane epithelzellinien der leber
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
ATE135041T1 (de) Verfahren zur herstellung von faktorabhängigen menschlichen b-zellinien
ZA988446B (en) Production of vaccines using arthropod vectored viruses.
BR9612115A (pt) Inibidor de proliferação de célula endotelial e processo de uso
DE68908223D1 (de) Verfahren zur herstellung von sehr reiner, dichter grossteiliger kieselsaeure.
WO2004056976A3 (en) Process for coating cell-culture support
WO1998006827A3 (en) Method for immortalizing cells
ATE196652T1 (de) In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen
DK0876532T3 (da) Fremgangsmåde til fremstilling af en impermeabel membran og tagbeklædning og produkter opnået ved hjælp af fremgangsmåden
PT1019526E (pt) Metodo para determinar actividade de canal ionico de uma substancia
ATE522604T1 (de) Verfahren zur herstellung von proteinen durch elektropulsierung
DK526889A (da) Apparat til gennemfoerelse af membranskilleprocesser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties